locally advanced head and neck squamous cell carcinoma (HNSCC), including but not limited to oral cancer, oropharyngeal cancer, laryngeal cancer, and hypopharyngeal cancer.
Conditions
Interventions
Sponsors
Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The patient or their legal guardian agrees to participate in the study, voluntarily joins the study, and signs the informed consent form. 2. Patients with head and neck malignant tumors who are aged >=18 years. 3. Confirmed by pathology or cytology, and suitable for neoadjuvant treatment with toripalimab in combination with chemotherapy. 4. Patients with complete clinical data and nursing records, who can provide information about their treatment experience and nursing perceptions. 5. Case records of patients who receive neoadjuvant treatment with toripalimab in combination with chemotherapy during the study period.
Exclusion criteria
Exclusion criteria: 1. Patients who refuse to participate in the study or are unable to provide informed consent. 2. Patients with severe dysfunction of important organs such as the heart, lungs, liver, or kidneys, which may affect the evaluation of treatment outcomes. 3. Patients who are simultaneously participating in other clinical trials that may influence the results of this study. 4. Cases lacking key information (such as nursing interventions or patient feedback). 5. Cases where patients develop significant complications during treatment or are transferred to other medical institutions, resulting in an incomplete record of the nursing process. 6. Patients with mental illness or cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The psychological experience, physical sensation, and subjective perception of nursing needs of patients during and after treatment.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Knowledge mastery level;Improvement in quality of life;Improvement of self-care ability; | — |
Countries
China
Contacts
Public ContactHu Zidan
Shenzhen Second People's Hospital
Outcome results
None listed